Halothane hepatotoxicity in hyperthyroid rats as compared to the phenobarbital-hypoxia model
- 1 June 1983
- journal article
- research article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 69 (2) , 257-264
- https://doi.org/10.1016/0041-008x(83)90306-x
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- The mechanism of reductive dehalogenation of halothane by liver cytochrome P450Biochemical Pharmacology, 1982
- Glutathione Thresholds in Reactive Metabolite ToxicityPublished by Springer Nature ,1980
- Hepatotoxicity and Halothane Metabolism in an Animal Model with Application for Human ToxicityAnaesthesia and Intensive Care, 1979
- Dose-dependent actions of thyroxine on hepatic drug metabolism in male and female ratsBiochemical Pharmacology, 1978
- Halothane hepatotoxicity and the reduced derivative, 1,1,1-trifluoro-2-chloroethane.Environmental Health Perspectives, 1977
- 1,1‐Dichloroethylene hepatotoxic1ty: Effect of altered thyroid function and evidence for the subcellular site of injuryJournal of Toxicology and Environmental Health, 1977
- Urinary Metabolites of Halothane in ManAnesthesiology, 1975
- Distribution of enzymes that catalyse reactions of glutathione with αβ-unsaturated compoundsBiochemical Journal, 1973
- Halothane Biotransformation in ManAnesthesiology, 1967
- Tissue sulfhydryl groupsArchives of Biochemistry and Biophysics, 1959